Page Tools:

100 Questions & Answers About Uterine Cancer

Author(s): Don S. Dizon, MD, FACP, Associate Professor, Obstetrics & Gynecology and Medicine, Brown Medical School/Women & Infants' Hospital of Rhode Island, Providence, Rhode Island
Linda R. Duska, MD, Associate Professor, Gynecology Fellowship Director, University of VA School of Medicine, Charlottesville, Virginia
Details:
  • ISBN-13: 9780763776589
  • Paperback    134 pages      © 2011
Price: $21.95 US List
Add to Cart

Whether you are a newly diagnosed uterine cancer patient, a survivor, or a friend or relative of either, this book offers help. 100 Questions and Answers About Uterine Cancer addresses the issues that are specific to the woman with uterine cancer. Written by two renowned gynecologic oncologists and including “insider” advice from an actual patient, this book gives you authoritative, practical answers to your questions about uterine cancer. It explains important facts about symptoms and the diagnosis process, treatment options, post-treatment quality of life, coping strategies, and sources of patient and family support. This book is an invaluable resource for anyone dealing with the physical and emotional turmoil of this frightening disease.

Part  1  The Basics
Part  2  Risk Factors
Part  3  Uterine Epithelial Cancer
Part  4  Treatment of Epithelial Cancers of the Uterus
Part  5  Uterine Sarcomas
Part  6  Gestational Trophoblast Neoplasis
Part  7  Treating Recurrent Uterine Cancer
Part  8  Treatment at the End-of-Life
Part  9  Survivorship Issues for Women with Uterine Cancer

Don S. Dizon, MD, FACP-Associate Professor, Obstetrics & Gynecology and Medicine, Brown Medical School/Women & Infants' Hospital of Rhode Island, Providence, Rhode Island

Dr. Dizon holds a dual appointment as Associate Professor in both Obstetrics and Gynecology and Medicine at The Warren Alpert Medical School of Brown University. He is a 1991 graduate of the University of Rochester School of Medicine and Dentistry and trained in Internal Medicine at Yale New-Haven Hospital followed by Medical Oncology specialization at Memorial Sloan-Kettering Cancer Center (MSKCC). While at MSKCC he developed expertise in gynecologic malignancies and received a Career Development Award from the American Society of Clinical Oncology for work on platinum drug resistance. He was a member of the Developmental Therapeutics faculty and Gynecology Disease Management Team of Memorial Sloan-Kettering Cancer Center until 2003 when he assumed his current role as the director of Medical Oncology for the Program in Women’s Oncology of Women & Infants’ Hospital of Rhode Island, where he also serves as the Medical Director of the Program’s Integrative Care Program. In 2005 he helped establish the state’s first Center for Sexuality, Intimacy, and Fertility for women with cancer.  In 2005 he was elected Fellow of the American College of Physicians (ACP) and he is currently on the Board of Directors for the Rhode Island chapter of the ACP.  Nationally, he continues to pursue research in the novel treatments of both breast and gynecological cancers and is active in the Gynecologic Oncology Group, serving on Phase I, Developmental Therapeutics, and Cervix committees. He is the President of the National Consortium of Breast Centers and has federal funding to further explore the role of social networks in advance care planning of women with cancer.
Additional Titles by this Author

Linda R. Duska, MD-Associate Professor, Gynecology Fellowship Director, University of VA School of Medicine, Charlottesville, Virginia

Dr. Duska is an Associate Professor of Obstetrics and Gynecology in the Division of Gynecologic Oncology at the University of Virginia (UVA) where she is also the Gynecologic Oncology Fellowship Director. Dr. Duska received her Doctor of Medicine from the New York University School of Medicine and completed her Residency in Obstetrics and Gynecology at the Johns Hopkins Hospital in Baltimore, MD. Upon completion of her Fellowship in Gynecologic Oncology at Massachusetts General Hospital (MGH) in Boston, she joined the Gynecologic Oncology staff at the Massachusetts General Hospital and was a member of the faculty of Harvard University for 10 years prior to relocating to UVA.